A. Characteristics of graft rejection. Data are shown as median (IQR) and n (%). *biopsy proven. ICI; immune checkpoint inhibitor, PD-1; programmed cell death protein 1, CTLA-4; cytotoxic T-lymphocyte-associated protein 4, TCMR; T-cell mediated rejection, ABMR; antibody mediated rejection, IVIg; intravenous immunoglobulin. B. Distribution of timing between ICI initiation and graft rejection, and cumulative rate of events is shown.